Optimization of Influenza Vaccine Selection

The World Health Organization (WHO) recommends which strains of influenza to include in each year's vaccine to countries around the globe. The current WHO strategy attempts to match the vaccine strains with the expected upcoming epidemic strains, a strategy we refer to as thefollow policy. The recently proposed antigenic distance hypothesis suggests that vaccine efficacy can be enhanced by taking into account the antigenic histories of vaccinees. To assess the potential benefit of history-based vaccination, we formulate the annual vaccine-strains selection problem as a stochastic dynamic program using the theory of shape space, which maps each vaccine and epidemic strain into a point in multidimensional space. Computational results show that a near-optimal policy can be derived by approximating the entire antigenic history by a single reduced historical strain, and then solving the multiperiod problem myopically, as a series of single-period problems. The modest suboptimality of the follow policy, together with our current inability to quantitatively link the model's objective function (a measure of cross-reactivity) with actual vaccine efficacy, leads us to recommend the continued use of the follow policy.

[1]  J. Gog,et al.  Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Derek J. Smith,et al.  Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. , 2003, Vaccine.

[3]  C. Gerdil The annual production cycle for influenza vaccine. , 2003, Vaccine.

[4]  Jonathan Dushoff,et al.  Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R Farber,et al.  The geometry of shape space: application to influenza. , 2001, Journal of theoretical biology.

[6]  W. Fitch,et al.  Predicting the evolution of human influenza A. , 1999, Science.

[7]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Gross,et al.  Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization. , 1999, Vaccine.

[9]  A. Osterhaus,et al.  Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. , 1999, Archives of internal medicine.

[10]  R B Couch,et al.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.

[11]  H. Sacks,et al.  The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.

[12]  Dimitri P. Bertsekas,et al.  Dynamic Programming and Optimal Control, Two Volume Set , 1995 .

[13]  G. Oster,et al.  Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination. , 1979, Journal of theoretical biology.

[14]  Christine Miller,et al.  ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITAL , 1979, The Lancet.